Exelixis, INC. (EXEL) — 10-Q Filings

All 10-Q filings from Exelixis, INC.. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.

10-Q Filings (6)

Exelixis Q3 Net Income Soars 41% on Strong Product Sales — Nov 4, 2025 Risk: medium
EXELIXIS, INC. reported a strong financial performance for the nine months ended September 30, 2025, with total revenues increasing to $1,721,463 thousand, up f
Exelixis Q2 Revenue Jumps on Strong Product Sales — Jul 28, 2025 Risk: medium
EXELIXIS, INC. reported product revenue of $415.0 million for the quarter ended July 4, 2025, a significant increase from $370.0 million in the prior-year quart
Exelixis, Inc. Files Q1 2025 10-Q Report — May 13, 2025 Risk: low
Exelixis, Inc. filed its 10-Q for the period ending April 4, 2025. The company, based in Alameda, CA, operates in the biological products sector. Key financial
Exelixis Files 10-Q for Q3 2024 — Oct 29, 2024 Risk: medium
Exelixis, Inc. filed its 10-Q for the period ending September 27, 2024. The company reported financial results and provided updates on its business operations.
Exelixis Files 10-Q for Q2 2024 — Aug 6, 2024 Risk: medium
Exelixis, Inc. filed its 10-Q for the period ending June 28, 2024. The filing details financial performance and business operations, including revenue generated
Exelixis, Inc. Files 10-Q for Period Ending March 29, 2024 — Apr 30, 2024 Risk:
EXELIXIS, INC. (EXEL) filed a Quarterly Report (10-Q) with the SEC on April 30, 2024. Exelixis, Inc. filed a 10-Q report for the period ending March 29, 2024. T

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX